In 2006, Anne Wojcicki cofounded 23andMe to help people access, understand, and benefit from the human genome, and she now serves as the company’s CEO. In this Radcliffe Institute program, Wojcicki will discuss the evolving benefits of genomic science, including the company’s crowdsourced research platform. This platform has played a role in creating one of the largest COVID-19 research studies, exploring whether genetics plays a role in the severity or susceptibility to the virus, and is helping to drive the discovery of novel, genetically validated therapeutic targets to bring new medicines to patients.
Free and open to the public. To view this event online, individuals will need to register via Zoom.
For instructions on how to join, see the How to Attend a Radcliffe Event on Zoom webpage.
After registering, you will receive a confirmation e-mail containing a link and password for this meeting.
Live closed captioning will be available for this webinar.